Novo Nordisk, maker with the brands, will successfully drop its current market exclusivity on Those people medication in Canada in January, opening the door to generic variations.What that means for you personally is always that in lots of conditions, your insurance won't go over the costs of GLP-1 medication Unless of course you demonstrate tha